| |
| | NIH/NHLBI News Release--WHI Study Finds No Heart Disease Benefit, Increased Stroke Risk With Estrogen Alone |
 | | The estrogen-alone study was stopped at the end of February 2004 because the hormone increased the risk of stroke and did not reduce the risk of coronary heart disease, a key question of the trial. |
 | | It was halted in July 2002 after 5.6 years of followup because of an increased risk of breast cancer and because the increased risks of breast cancer, coronary heart disease, stroke, and blood clots outweighed the benefits of a reduced risk of hip fracture and colorectal cancer. |
 | | WHI was launched in 1991 and consists of a set of clinical trials to test the preventive effects of postmenopausal hormone therapy, diet modification, and calcium and vitamin D supplements on heart disease, fractures, breast and colorectal cancer, as well as an observational study, which is looking for predictors and biological markers for disease. |
| www.nhlbi.nih.gov /new/press/04-04-13.htm (1191 words) |
|